Black Diamond Therapeutic...

NASDAQ: BDTX · Real-Time Price · USD
2.76
-0.03 (-1.08%)
At close: Aug 15, 2025, 3:59 PM
2.77
0.36%
After-hours: Aug 15, 2025, 07:30 PM EDT

Black Diamond Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-10.56M 56.54M -15.98M -15.56M -19.91M -18.23M -19.41M -23.01M -19.15M -20.88M -21.08M -21.65M -22.93M -25.51M -25.87M -35.08M -34.35M -30.3M
Depreciation & Amortization
86K 87K 85K 86K 86K 86K 86K 115K 114K 122K 126K 129K 128K 125K 123K 43K 20K 19K
Stock-Based Compensation
1.78M 1.7M 1.64M 1.99M 5.29M 1.71M 1.54M 2.75M 2.65M 2.67M 2.91M 2.66M 3.25M 3.38M 3.38M 3.01M 4.56M 3.09M
Other Working Capital
n/a -3.88M -2.85M 1.27M 650K -3.44M 2.29M 3.1M 1.65M -1.17M -780K -1.93M 323K -5.29M -2.04M 3.84M 3.94M -298K
Other Non-Cash Items
-461K -1.04M 25K -320K 5.49M 2.81M -17K 708K 698K 836K 770K 774K 821K 918K 691K 582K 413K 321K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -78K -170K 21K n/a n/a n/a n/a n/a 362K 491K 607K 719K
Change in Working Capital
n/a -5.26M -816K 2.48M 217K -4.57M 3.92M 1.24M 1.3M -2.79M -4.66M 1.61M 662K -7.51M -2.73M 4.47M 3.59M 1.69M
Operating Cash Flow
-9.16M 53.41M -15.05M -11.32M -14.73M -21.2M -13.96M -18.36M -14.37M -20.03M -21.94M -16.48M -18.07M -28.6M -24.05M -26.48M -25.16M -24.45M
Capital Expenditures
n/a n/a n/a n/a 14.73M n/a 33K -33K n/a n/a 200K 8K -193K -7K -333K -1.49M -848K -40K
Cash Acquisitions
n/a n/a 8K n/a 38K n/a -132.85K 37.85K 95K n/a 9K -14.5K n/a 7K 2.7M n/a n/a 39K
Purchase of Investments
-89.75M -23.47M -2.99M -27.86M -39.8M -52.23M -15.79M -46.1M n/a n/a -23.69M -15.95M n/a -20.5M -4.92M -2.01M -1.05M -41.53M
Sales Maturities Of Investments
30.58M 32M 30.75M 30M 40.5M 38.5M 28.04M 8.25M 17.08M 24.81M 26M 30.45M 20M 37.24M 48.5M 39.19M 50.1M 45.04M
Other Investing Acitivies
13K 13K 8K 48K 740K -13.73M 12.25K -37.85K 17.18K 24.81K -200K 14.5K 20K -7K -2.7M 37.19M 49.05M -39K
Investing Cash Flow
-59.15M 8.55M 27.77M 2.19M 740K -13.73M 12.25M -37.88M 17.18M 24.81M 2.32M 14.51M 19.81M 16.73M 43.24M 35.7M 48.2M 3.47M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a -46 n/a n/a n/a -28 n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-116K 32K 291K 248K 364K 150K n/a 77K n/a 51K -28K 52K n/a 153K -729K 64K 184K 481K
Financial Cash Flow
-116K 32K 291K -252K 21.38M 4.13M -46K 71.93M n/a 51K -28K 52K n/a 153K n/a 64K 184K 481K
Net Cash Flow
-68.43M 61.99M 13.01M -8.56M 7.39M -30.8M -1.76M 15.68M 2.81M 4.83M -19.64M -1.92M 1.74M -11.72M 19.2M 9.28M 23.22M -20.5M
Free Cash Flow
-9.16M 53.41M -15.05M -11.32M n/a -21.2M -13.92M -18.39M -14.37M -20.03M -21.74M -16.47M -18.26M -28.61M -24.38M -27.97M -26.01M -24.5M